Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gustafsson

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Human Hypertension|September 12, 2008
New risk markers may change the HeartScore risk classification significantly in one-fifth of the populationM H Olsen, T W Hansen, M K Christensen, et al.
Internal Medicine Journal|November 6, 2014
Hyponatraemia at hospital admission is a predictor of overall mortalityL Balling, F Gustafsson, J P Goetze, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 10, 2017
Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable?C Ekenberg, I P Lodding, N E Wareham, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 22, 2014
Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trialA K Andreassen, B Andersson, F Gustafsson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 29, 2016
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE StudyA K Andreassen, B Andersson, F Gustafsson, et al.
Open Forum Infectious Diseases|June 8, 2018
Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell TransplantationI P Lodding, C da Cunha Bang, S S Sørensen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 14, 2016
The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infectionNeval E Wareham, J D Lundgren, C Da Cunha-Bang, et al.
Cardiovascular Drugs and Therapy|November 8, 2018
Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic ApplicationS Bouchez, F Fedele, G Giannakoulas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 4, 2013
The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infectionC da Cunha-Bang, N Kirkby, M Sønderholm, et al.
Ebiomedicine|August 20, 2015
Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus InfectionsI P Lodding, H Sengeløv, C da Cunha-Bang, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Human Hypertension|September 12, 2008
New risk markers may change the HeartScore risk classification significantly in one-fifth of the populationM H Olsen, T W Hansen, M K Christensen, et al.
Internal Medicine Journal|November 6, 2014
Hyponatraemia at hospital admission is a predictor of overall mortalityL Balling, F Gustafsson, J P Goetze, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 10, 2017
Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable?C Ekenberg, I P Lodding, N E Wareham, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 22, 2014
Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trialA K Andreassen, B Andersson, F Gustafsson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 29, 2016
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE StudyA K Andreassen, B Andersson, F Gustafsson, et al.
Open Forum Infectious Diseases|June 8, 2018
Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell TransplantationI P Lodding, C da Cunha Bang, S S Sørensen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 14, 2016
The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infectionNeval E Wareham, J D Lundgren, C Da Cunha-Bang, et al.
Cardiovascular Drugs and Therapy|November 8, 2018
Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic ApplicationS Bouchez, F Fedele, G Giannakoulas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 4, 2013
The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infectionC da Cunha-Bang, N Kirkby, M Sønderholm, et al.
Ebiomedicine|August 20, 2015
Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus InfectionsI P Lodding, H Sengeløv, C da Cunha-Bang, et al.
Pageof 5